UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

U.S. equities were mixed at midday, with the Dow Jones Industrial Average and S&P 500 slightly higher and the Nasdaq marginally lower.

The Wall Street Journal in a recent report citing unnamed individuals stated that the US Department of Justice was investigating UnitedHealth Group for potential Medicare fraud.

UNH shares plunge impacts 391 ETFs, shaking institutional & retail investors. Explore top ETFs most affected and what's behind the company's downturn.

UnitedHealth Group's stock has collapsed nearly 50% in 2025 after a leadership shake-up, surging medical costs, and a DOJ criminal probe into Medicare fraud.

UnitedHealth faces valuation reset amid CEO change, regulatory probes, and cost overruns. Click here for a full analysis of UNH stock.

It created a fandom culture around his accused shooter, Luigi Mangione, and an endless cycle of cheerleading and scolding in response. Prosecutors have prosecuted. Editorial boards have editorialized.